A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia

详细信息    查看全文

• 作者：Ashleigh L. Osborne^a ; ^c ; ^d ; Nadia Solowij^b ; ^c ; Katrina Weston-Green^a ; ^c ; ^d ; ^{katrina_green@uow.edu.au}
• 关键词：Cannabidiol ; Cognition ; Antipsychotic drugs ; Cognitive impairment ; Schizophrenia ; Neuropsychiatric ; Neurodegeneration ; Alzheimer&rsquo ; s disease ; Neuro-inflammation ; Meningitis ; Sepsis ; Cerebral malaria ; Hepatic encephalopathy ; Brain ischemia ; Δ9-Tetrahydrocannabinol ; Cannabis ; Cognitive testing
• 刊名：Neuroscience & Biobehavioral Reviews
• 出版年：2017
• 出版时间：January 2017
• 年：2017
• 卷：72
• 期：Complete
• 页码：310-324
• 全文大小：1028 K
• 卷排序：72

文摘

Evidence assessing the effect of CBD on cognition in schizophrenia is limited. Acute and chronic CBD treatment improves cognition in Alzheimer’s disease models. CBD improves cognitive impairment in neuro-inflammatory and neurological disorders. There is no significant effect of CBD on cognitive function in ‘healthy’ states.